{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:13:40Z","timestamp":1788488020313,"version":"build-2803163510"},"reference-count":318,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":93,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010564","name":"Deutsches Zentrum f\u00fcr Lungenforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["955575"],"award-info":[{"award-number":["955575"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008848","name":"Elitenetzwerk Bayern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002745","name":"Bayerische Forschungsstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["409510"],"award-info":[{"award-number":["409510"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021372","name":"Hector Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021372","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SA 1923\/7\\u20131"],"award-info":[{"award-number":["SA 1923\/7\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["A05"],"award-info":[{"award-number":["A05"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KO5055\/3\\u20131 SFB1213"],"award-info":[{"award-number":["KO5055\/3\\u20131 SFB1213"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390649896"],"award-info":[{"award-number":["390649896"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["A10N"],"award-info":[{"award-number":["A10N"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KO5055\\u20132\\u20131"],"award-info":[{"award-number":["KO5055\\u20132\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TRR 338\/1 2021\\u2013452881907"],"award-info":[{"award-number":["SFB-TRR 338\/1 2021\\u2013452881907"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010138","name":"Fritz-Bender-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70117182"],"award-info":[{"award-number":["70117182"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101168810"],"award-info":[{"award-number":["101168810"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["866051"],"award-info":[{"award-number":["866051"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.semcancer.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:15:58Z","timestamp":1778339758000},"page":"1-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor microenvironment evolution in lung cancer: Spatio-temporal dynamics and clinical implications"],"prefix":"10.1016","volume":"123-124","author":[{"given":"Selma","family":"Dizdarevi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Timofeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kazdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soni Savai","family":"Pullamsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Sotillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Loges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kobold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Stenzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Stiewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1538-2091","authenticated-orcid":false,"given":"Rajkumar","family":"Savai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2026.04.003_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/255197a0","article-title":"Mutation selection and the natural history of cancer","volume":"255","author":"Cairns","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The Hallmarks of Cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","article-title":"The multistep nature of cancer","volume":"9","author":"Vogelstein","year":"1993","journal-title":"Trends Genet"},{"key":"10.1016\/j.semcancer.2026.04.003_bib4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.1659741","article-title":"Tumor Suppressor Genes","volume":"254","author":"Weinberg","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.04.003_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.04.003_bib6","first-page":"2259","article-title":"Tumor heterogeneity","volume":"44","author":"Heppner","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.04.003_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbcan.2009.11.002","article-title":"Tumor heterogeneity: Causes and consequences","volume":"1805","author":"Marusyk","year":"2010","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib8","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: Wounds That Do Not Heal","volume":"315","author":"Flier","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/35094059","article-title":"Putting tumours in context","volume":"1","author":"Bissell","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s43556-025-00248-9","article-title":"Tumor microbiome: roles in tumor initiation, progression, and therapy","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.semcancer.2026.04.003_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111016","article-title":"Cancer evolution: A means by which tumors evade treatment","volume":"133","author":"Zhu","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.semcancer.2026.04.003_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","article-title":"Clinical implications of intratumor heterogeneity: challenges and opportunities","volume":"98","author":"Ram\u00f3n Y Cajal","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1116809","article-title":"Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer","volume":"13","author":"Fang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib14","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.3390\/cancers15102709","article-title":"Intratumoral Heterogeneity in Lung Cancer","volume":"15","author":"Lv","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.04.003_bib15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/cancers17061027","article-title":"Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy","volume":"17","author":"Oh","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.04.003_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","author":"Araghi","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.semcancer.2026.04.003_bib17","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200247","article-title":"Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories","volume":"11","author":"Hynds","year":"2021","journal-title":"Open Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib18","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the Evolution of Non\u2013Small-Cell Lung Cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib19","doi-asserted-by":"crossref","first-page":"a040972","DOI":"10.1101\/cshperspect.a040972","article-title":"The Evolution and Ecology of Resistance in Cancer Therapy","volume":"10","author":"Gatenby","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib20","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1158\/0008-5472.CAN-15-1337","article-title":"Application of Evolutionary Principles to Cancer Therapy","volume":"75","author":"Enriquez-Navas","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.04.003_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jtho.2024.11.021","article-title":"Final Overall Survival and Long-Term Safety of Lorlatinib in Patients With ALK-Positive NSCLC From the Pivotal Phase 2 Study: A Brief Report","volume":"20","author":"Ou","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJMoa2510308","article-title":"Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC","volume":"394","author":"J\u00e4nne","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa2310532","article-title":"Alectinib in Resected ALK -Positive Non\u2013Small-Cell Lung Cancer","volume":"390","author":"Wu","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.582884","article-title":"Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies","volume":"10","author":"Benavente","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00109-016-1401-8","article-title":"Therapy-induced microenvironmental changes in cancer","volume":"94","author":"Ma","year":"2016","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2026.04.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217241","article-title":"Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions","volume":"604","author":"Gang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.04.003_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.04.003_bib31","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.21037\/jtd.2018.11.102","article-title":"Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors","volume":"11","author":"Berland","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.semcancer.2026.04.003_bib32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/cancers15020504","article-title":"Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer","volume":"15","author":"Chhouri","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.04.003_bib33","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.21037\/tlcr-20-522","article-title":"Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells","volume":"9","author":"Clement","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117214","article-title":"ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race","volume":"242","author":"Ashton","year":"2025","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.semcancer.2026.04.003_bib35","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","article-title":"Acquired Resistance to KRASG12C Inhibition in Cancer","volume":"384","author":"Awad","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fevo.2021.681121","article-title":"Evolutionary Dynamics of Treatment-Induced Resistance in Cancer Informs Understanding of Rapid Evolution in Natural Systems","volume":"9","author":"Pressley","year":"2021","journal-title":"Front. Ecol. Evol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib37","doi-asserted-by":"crossref","unstructured":"Mathematical analysis and simulations involving chemotherapy and surgeryon large human tumours under a suitable cell-kill functional response, Math. Biosci. Eng. 10 (2013) 221\u2013234. https:\/\/doi.org\/10.3934\/mbe.2013.10.221.","DOI":"10.3934\/mbe.2013.10.221"},{"key":"10.1016\/j.semcancer.2026.04.003_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.1610021","article-title":"Predictive Role of Tumor-Stroma Ratio for Survival of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis","volume":"27","author":"Zhang","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib39","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3390\/cancers16091727","article-title":"The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression","volume":"16","author":"Buruian\u0103","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.04.003_bib40","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.21037\/jtd.2017.09.29","article-title":"Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival","volume":"9","author":"Xi","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.semcancer.2026.04.003_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110639","article-title":"Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma","volume":"39","author":"Altorki","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2026.04.003_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-019-1032-7","article-title":"Neoantigen-directed immune escape in lung cancer evolution","volume":"567","author":"The TRACERx consortium","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib43","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-15-1434","article-title":"Epithelial\u2013Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma","volume":"22","author":"Lou","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656364","article-title":"Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance","volume":"12","author":"Khalaf","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41423-023-00980-8","article-title":"Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy","volume":"20","author":"Gu","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104457","article-title":"Novel insights into immune cells modulation of tumor resistance","volume":"202","author":"Zhou","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","article-title":"Immune cell promotion of metastasis","volume":"15","author":"Kitamura","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82998","article-title":"The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures","volume":"12","author":"Bal\u00e1\u017eov\u00e1","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.semcancer.2026.04.003_bib49","article-title":"The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer","volume":"12","author":"Sun","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104284","article-title":"Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets","volume":"196","author":"Huang","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3892\/ol.2022.13476","article-title":"Tumor\u2011associated macrophage\u2011derived exosomes promote EGFR\u2011TKI resistance in non\u2011small cell lung cancer by regulating the AKT, ERK1\/2 and STAT3 signaling pathways","volume":"24","author":"Yuan","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2026.04.003_bib52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13046-019-1166-3","article-title":"Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src\/CD155\/MIF functional pathway","volume":"38","author":"Huang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Casanova-Acebes","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40164-024-00587-3","article-title":"Identification of a novel subtype of SPP1 + macrophages expressing SIRP\u03b1: implications for tumor immune evasion and treatment response prediction","volume":"13","author":"Chen","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib55","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41419-024-07074-x","article-title":"Novel FABP4+C1q+ macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK\/JAK\/STAT axis","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2026.04.003_bib56","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.21037\/tlcr-24-379","article-title":"Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence","volume":"13","author":"Zhao","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ccell.2023.03.019","article-title":"Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer","volume":"41","author":"Weeden","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib58","doi-asserted-by":"crossref","unstructured":"Y. Wang, Z. Guo, A. Xu, Z. Fu, Y. Hou, K. Tang, J. Li, F. Zhao, L. Chen, Mechanistic Insights into IL-6-Mediated NK Cell Dysfunction in NSCLC via the IRE1\u03b1-XBP1s-STAT3-UBE2S Axis, (2025). https:\/\/doi.org\/10.21203\/rs.3.rs-6438846\/v1.","DOI":"10.21203\/rs.3.rs-6438846\/v1"},{"key":"10.1016\/j.semcancer.2026.04.003_bib59","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1304790110","article-title":"Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia","volume":"110","author":"Baginska","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","article-title":"Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression","volume":"28","author":"Cong","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.04.003_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nm.2084","article-title":"Neutrophil elastase\u2013mediated degradation of IRS-1 accelerates lung tumor growth","volume":"16","author":"Houghton","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1476-4598-12-154","article-title":"Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase","volume":"12","author":"Gong","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib63","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","article-title":"High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer","volume":"40","author":"Salcher","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1759-7714.13719","article-title":"Single-cell transcriptome analysis of tumor-infiltrating B cells reveals their clinical implications in non-small cell lung cancer","volume":"12","author":"Diao","year":"2021","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib65","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13059-020-02064-6","article-title":"Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer","volume":"21","author":"Chen","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1198665","article-title":"Deep immune B and plasma cell repertoire in non-small cell lung cancer","volume":"14","author":"Patel","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib68","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00262-025-03973-w","article-title":"Revealing the role of regulatory b cells in cancer: development, function and treatment significance","volume":"74","author":"Ye","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2026.04.003_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.626776","article-title":"Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients","volume":"12","author":"Germain","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005539","article-title":"Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer","volume":"11","author":"He","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005531","article-title":"Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer","volume":"10","author":"Sun","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1423775","article-title":"Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer","volume":"15","author":"Xin","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12890-024-02970-6","article-title":"Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer","volume":"24","author":"Xiaoxu","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib75","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","article-title":"The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions","volume":"42","author":"MacFawn","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib76","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib77","article-title":"Cancer-associated fibroblasts facilitate DNA damage repair by promoting the glycolysis in non-small cell lung cancer","volume":"1869","author":"Zhang","year":"2023","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"key":"10.1016\/j.semcancer.2026.04.003_bib78","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1186\/s12885-022-09877-7","article-title":"Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer","volume":"22","author":"Feng","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib79","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","article-title":"Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib80","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12672-025-01974-w","article-title":"Modulation of almonertinib resistance in non-small cell lung cancer by cancer-associated fibroblasts through HK2-mediated glycolysis and SKP2 signaling","volume":"16","author":"Wei","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib81","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1940675","article-title":"T cells drive negative feedback mechanisms in cancer associated fibroblasts, promoting expression of co-inhibitory ligands, CD73 and IL-27 in non-small cell lung cancer","volume":"10","author":"O\u2019Connor","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.semcancer.2026.04.003_bib82","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3390\/cancers12092687","article-title":"Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities","volume":"12","author":"Freeman","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.04.003_bib83","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4046\/trd.2022.0129","article-title":"Immune Regulatory Function of Cancer- Associated Fibroblasts in Non-small Cell Lung Cancer","volume":"86","author":"Lee","year":"2023","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.semcancer.2026.04.003_bib84","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2021.05.009","article-title":"Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectives","volume":"514","author":"Zhang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.04.003_bib85","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12943-024-02221-6","article-title":"Unveiling the immunomodulatory dance: endothelial cells\u2019 function and their role in non-small cell lung cancer","volume":"24","author":"Daum","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib86","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib87","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","article-title":"Single-Cell Transcriptome Atlas of Murine Endothelial Cells","volume":"180","author":"Kalucka","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib88","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2019.12.001","article-title":"An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates","volume":"37","author":"Goveia","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib89","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","article-title":"An integrated cell atlas of the lung in health and disease","volume":"29","author":"Sikkema","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib90","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.csbj.2022.12.049","article-title":"Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues","volume":"21","author":"Zhang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.semcancer.2026.04.003_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2019.06.004","article-title":"Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages","volume":"81","author":"Xia","year":"2019","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1365760","article-title":"Schwann cells in the normal and pathological lung microenvironment","volume":"11","author":"Shurin","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.784","article-title":"Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk","volume":"5","author":"Fan","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.semcancer.2026.04.003_bib94","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-018-0901-2","article-title":"Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer","volume":"17","author":"Schaal","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.169604","article-title":"The role of \u03b17-nAChR-mediated PI3K\/AKT pathway in lung cancer induced by nicotine","volume":"912","author":"He","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.semcancer.2026.04.003_bib96","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","article-title":"\u03b2-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy","volume":"77","author":"Bucsek","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.04.003_bib97","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13046-024-03202-9","article-title":"Mechanisms of neural infiltration-mediated tumor metabolic reprogramming impacting immunotherapy efficacy in non-small cell lung cancer","volume":"43","author":"Zheng","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib98","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00072311","article-title":"Circulating fibrocytes are increased in children and young adults with pulmonary hypertension","volume":"39","author":"Yeager","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.semcancer.2026.04.003_bib99","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12931-018-0798-8","article-title":"Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Heukels","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2015.07.037","article-title":"Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity","volume":"137","author":"Shipe","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib101","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/bph.15025","article-title":"Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model","volume":"177","author":"Nikam","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.semcancer.2026.04.003_bib102","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol. Med. Camb. Mass"},{"key":"10.1016\/j.semcancer.2026.04.003_bib103","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1038\/s41467-022-33458-8","article-title":"Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system","volume":"13","author":"Weigert","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib104","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.4049\/jimmunol.1202857","article-title":"Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2","volume":"190","author":"Van Deventer","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2018.02.016","article-title":"Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells","volume":"421","author":"Saijo","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.04.003_bib106","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib107","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.semcancer.2026.04.003_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014062","article-title":"Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties","volume":"5","author":"Leung","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcancer.2026.04.003_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000243","article-title":"Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer","volume":"2","author":"Gutova","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcancer.2026.04.003_bib110","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/cas.13520","article-title":"Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib111","first-page":"1","article-title":"WDR72 Enhances the Stemness of Lung Cancer Cells by Activating the AKT\/HIF-1\u03b1 Signaling Pathway","volume":"2022","author":"Ouyang","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib112","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.1424171112","article-title":"Suppression of cancer relapse and metastasis by inhibiting cancer stemness","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib113","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1042\/BCJ20170164","article-title":"Cancer stem cells (CSCs): metabolic strategies for their identification and eradication","volume":"475","author":"De Francesco","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2026.04.003_bib114","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12964-023-01281-3","article-title":"Exosomal lncRNA Mir100hg derived from cancer stem cells enhance glycolysis and promote metastasis of lung adenocarcinoma through mircroRNA-15a-5p\/31-5p","volume":"21","author":"Shi","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.semcancer.2026.04.003_bib115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13287-024-04061-z","article-title":"Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies","volume":"15","author":"Li","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.semcancer.2026.04.003_bib116","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-017-0600-4","article-title":"Intra-tumor heterogeneity from a cancer stem cell perspective","volume":"16","author":"Prasetyanti","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib118","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","article-title":"Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy","volume":"15","author":"Jiang","year":"2022","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib119","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1159\/000430297","article-title":"Syndecan-4 Promotes Epithelial Tumor Cells Spreading and Regulates the Turnover of PKC\u03b1 Activity under Mechanical Stimulation on the Elastomeric Substrates","volume":"36","author":"Huang","year":"2015","journal-title":"Cell. Physiol. Biochem"},{"key":"10.1016\/j.semcancer.2026.04.003_bib120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1194515","article-title":"Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer","volume":"13","author":"Titmarsh","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib122","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13073-022-01127-6","article-title":"Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma","volume":"14","author":"Parker","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.semcancer.2026.04.003_bib123","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003052","article-title":"The end of the genetic paradigm of cancer","volume":"23","author":"Huang","year":"2025","journal-title":"PLOS Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib125","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib126","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib127","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"International Human Genome Sequencing Consortium","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib128","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The Sequence of the Human Genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.04.003_bib129","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108389","article-title":"Cancer evolution: Darwin and beyond","volume":"40","author":"Vendramin","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2026.04.003_bib130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib131","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm.3915","article-title":"Toward understanding and exploiting tumor heterogeneity","volume":"21","author":"Alizadeh","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib132","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41698-018-0063-0","article-title":"Tumor evolution and chemoresistance in ovarian cancer","volume":"2","author":"Kim","year":"2018","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib133","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2017.01.003","article-title":"Tumor evolution: Linear, branching, neutral or punctuated?","volume":"1867","author":"Davis","year":"2017","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib134","doi-asserted-by":"crossref","first-page":"29761","DOI":"10.18632\/oncotarget.8858","article-title":"Genetic changes of non-small cell lung cancer under neoadjuvant therapy","volume":"7","author":"Warth","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.04.003_bib135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"De Bruin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.04.003_bib136","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib137","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1256930","article-title":"Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing","volume":"346","author":"Zhang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.04.003_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa1408","article-title":"Clonal status of actionable driver events and the timing of mutational processes in cancer evolution","volume":"7","author":"McGranahan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib139","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s42003-025-07954-8","article-title":"Comprehensive multimodal and multiomic profiling reveals epigenetic and transcriptional reprogramming in lung tumors","volume":"8","author":"Wu","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrg.2016.13","article-title":"Epigenetic modulators, modifiers and mediators in cancer aetiology and progression","volume":"17","author":"Feinberg","year":"2016","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.semcancer.2026.04.003_bib141","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41467-021-21707-1","article-title":"Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains","volume":"12","author":"Gopi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib142","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/bies.201100031","article-title":"The molecular and mathematical basis of Waddington\u2019s epigenetic landscape: A framework for post-Darwinian biology?","volume":"34","author":"Huang","year":"2012","journal-title":"BioEssays"},{"key":"10.1016\/j.semcancer.2026.04.003_bib143","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global Epidemiology of Lung Cancer","volume":"85","author":"Barta","year":"2019","journal-title":"Ann. Glob. Health"},{"key":"10.1016\/j.semcancer.2026.04.003_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108101","article-title":"Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking","volume":"200","author":"Reuss","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib145","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1186\/s12885-024-12737-1","article-title":"Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers","volume":"24","author":"Garrido","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib146","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.3564","article-title":"Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas","volume":"48","author":"Cancer Genome Atlas Research Network","year":"2016","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2026.04.003_bib147","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2019.02.012","article-title":"Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis","volume":"176","author":"Petljak","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib148","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-023-05783-5","article-title":"The evolution of lung cancer and impact of subclonal selection in TRACERx","volume":"616","author":"Frankell","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib149","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-023-05706-4","article-title":"Genomic\u2013transcriptomic evolution in lung cancer and metastasis","volume":"616","author":"Mart\u00ednez-Ruiz","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib150","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","article-title":"Genome doubling shapes the evolution and prognosis of advanced cancers","volume":"50","author":"Bielski","year":"2018","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2026.04.003_bib151","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molcel.2023.11.002","article-title":"Boveri and beyond: Chromothripsis and genomic instability from mitotic errors","volume":"84","author":"Mazzagatti","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib152","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","article-title":"Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing","volume":"52","author":"Cort\u00e9s-Ciriano","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2026.04.003_bib153","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-020-03064-z","article-title":"Chromothripsis drives the evolution of gene amplification in cancer","volume":"591","author":"Shoshani","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib154","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41591-023-02230-w","article-title":"Evolutionary characterization of lung adenocarcinoma morphology in TRACERx","volume":"29","author":"Karasaki","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib155","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib156","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3390\/cancers12123605","article-title":"Immune Escape Mechanisms in Non Small Cell Lung Cancer","volume":"12","author":"Anichini","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.04.003_bib157","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/2159-8290.CD-17-0593","article-title":"Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer","volume":"7","author":"Gettinger","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.04.003_bib158","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41416-020-01232-6","article-title":"Understanding the impact of immune-mediated selection on lung cancer evolution","volume":"124","author":"Rosenthal","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib159","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41698-025-01003-7","article-title":"Epigenetic regulators in cancer therapy and progression","volume":"9","author":"Marei","year":"2025","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-8935-5-9","article-title":"Genome-wide DNA methylation profiling of non-small cell lung carcinomas","volume":"5","author":"Carvalho","year":"2012","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.semcancer.2026.04.003_bib161","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1158\/1078-0432.CCR-14-1087","article-title":"Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome","volume":"20","author":"Karlsson","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib162","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0710735105","article-title":"High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer","volume":"105","author":"Rauch","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib163","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12943-024-02035-6","article-title":"Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations","volume":"23","author":"Kaneko","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib164","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12964-024-01823-3","article-title":"Histone variant H2AZ1 drives lung cancer progression through the RELA-HIF1A-EGFR signaling pathway","volume":"22","author":"Zhao","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.semcancer.2026.04.003_bib165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccell.2022.11.015","article-title":"KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition","volume":"41","author":"Pan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib166","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-02494-x","article-title":"silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations","volume":"15","author":"Nieto-Jim\u00e9nez","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.04.003_bib167","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-24-2054","article-title":"Mutation of SMARCA4 Induces Cancer Cell\u2013Intrinsic Defects in the Enhancer Landscape and Resistance to Immunotherapy","volume":"85","author":"Wang","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.04.003_bib168","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","article-title":"Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer","volume":"24","author":"Lissanu Deribe","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib169","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","article-title":"H3K18 Lactylation Potentiates Immune Escape of Non\u2013Small Cell Lung Cancer","volume":"84","author":"Zhang","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.04.003_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117097","article-title":"Histone lactylation-driven YTHDF2 promotes non-small cell lung cancer cell glycolysis and stemness by recognizing m6A modification of SFRP2","volume":"240","author":"Zhao","year":"2025","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.semcancer.2026.04.003_bib171","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41419-024-07313-1","article-title":"CARM1-mediated OGT arginine methylation promotes non-small cell lung cancer glycolysis by stabilizing OGT","volume":"15","author":"Lin","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2026.04.003_bib172","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"De Zuani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular Mechanisms of Treg-Mediated T Cell Suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib174","article-title":"Advancing non-small cell lung cancer treatment: the power of combination immunotherapies","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib175","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3390\/ijms26072998","article-title":"PD-L1+ Regulatory B Cells from Rheumatoid Arthritis Patients Have Impaired Function in Suppressing IFN-\u04af and IL-21 Production","volume":"26","author":"Talib","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib176","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13046-025-03519-z","article-title":"Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib177","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12967-021-03112-w","article-title":"Immunobiology of cancer-associated fibroblasts in the context of radiotherapy","volume":"19","author":"Hellevik","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib178","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","article-title":"LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation","volume":"57","author":"Joller","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.04.003_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1103149","article-title":"Tumor\u2212associated macrophage polarization in the inflammatory tumor microenvironment","volume":"13","author":"Zou","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib181","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.intimp.2010.12.024","article-title":"Immunotherapeutic modulation of the suppressive liver and tumor microenvironments","volume":"11","author":"Chan","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib182","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.celrep.2017.06.062","article-title":"Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer","volume":"20","author":"Jang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2026.04.003_bib183","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457189","article-title":"Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations","volume":"15","author":"Ge","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.740827","article-title":"Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression","volume":"9","author":"Cheng","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12672-023-00793-1","article-title":"Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer","volume":"14","author":"He","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib186","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/ijc.28770","article-title":"Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17\u2014A new mechanism of impaired antitumor immunity","volume":"135","author":"Mishalian","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib187","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12672-024-01210-x","article-title":"CCL17, CCL22 and their receptor CCR4 in hematologic malignancies","volume":"15","author":"Zou","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib188","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.938289","article-title":"Roles of tumor-associated neutrophils in tumor metastasis and its clinical applications","volume":"10","author":"Yan","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101866","article-title":"Tumor associated neutrophils governs tumor progression through an IL-10\/STAT3\/PD-L1 feedback signaling loop in lung cancer","volume":"40","author":"Zhang","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib190","article-title":"Recent advances in regulatory immune cells: exploring the world beyond Tregs","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib191","article-title":"The immune tolerance role of Bregs in inhibiting human inflammatory diseases, with a focus on diabetes mellitus","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib192","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/or.2024.8714","article-title":"Advances of HIF\u20111\u03b1\/glycolysis axis in non\u2011small cell lung cancer (Review)","volume":"51","author":"Shi","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2026.04.003_bib193","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ccell.2023.05.015","article-title":"MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma","volume":"41","author":"Qian","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.04.003_bib194","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3390\/cancers16183142","article-title":"The Adenosinergic Pathway in Non-Small Cell Lung Cancer","volume":"16","author":"Van Kerkhove","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.04.003_bib195","article-title":"Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib196","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12935-024-03544-6","article-title":"Exosome therapeutics for non-small cell lung cancer tumorigenesis","volume":"24","author":"Orooji","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.semcancer.2026.04.003_bib197","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41420-025-02484-y","article-title":"Exosome-mediated ferroptosis in the tumor microenvironment: from molecular mechanisms to clinical application","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.semcancer.2026.04.003_bib198","article-title":"Functional tumor-derived exosomes in NSCLC progression and clinical implications","volume":"16","author":"Gao","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.semcancer.2026.04.003_bib199","article-title":"Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non-small-cell lung cancer","volume":"15","author":"Zhang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib200","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12931-021-01919-1","article-title":"Relationship of the lung microbiome with PD-L1 expression and immunotherapy response in lung cancer","volume":"22","author":"Jang","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib201","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fmed.2018.00085","article-title":"Overview on Clinical Relevance of Intra-Tumor Heterogeneity","volume":"5","author":"Stanta","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature12627","article-title":"Tumour heterogeneity in the clinic","volume":"501","author":"Bedard","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib203","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1183\/09031936.00018013","article-title":"EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype","volume":"43","author":"Warth","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.semcancer.2026.04.003_bib204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ijc.30437","article-title":"Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer","volume":"140","author":"Zhang","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib205","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41388-021-02141-5","article-title":"p53 partial loss-of-function mutations sensitize to chemotherapy","volume":"41","author":"Klimovich","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2026.04.003_bib206","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ijc.31893","article-title":"Identification of a highly lethal V3+ TP53+ subset in ALK+ lung adenocarcinoma","volume":"144","author":"Christopoulos","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib207","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2022.04.020","article-title":"The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions","volume":"170","author":"Christopoulos","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib208","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cllc.2017.04.014","article-title":"Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples","volume":"18","author":"Casadevall","year":"2017","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib209","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lungcan.2019.06.005","article-title":"Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response","volume":"134","author":"Haragan","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib210","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1016\/j.cllc.2018.02.008","article-title":"Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma","volume":"19","author":"Liu","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib211","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib212","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41591-019-0595-z","article-title":"A clonal expression biomarker associates with lung cancer mortality","volume":"25","author":"TRACERx Consortium","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib213","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s43018-024-00883-1","article-title":"Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma","volume":"6","author":"Biswas","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib214","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1634\/theoncologist.2016-0150","article-title":"Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer","volume":"22","author":"Dong","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.semcancer.2026.04.003_bib215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib216","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1200\/EDBK_158808","article-title":"Tumor Heterogeneity and Therapeutic Resistance","author":"Lovly","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.semcancer.2026.04.003_bib217","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7150\/ijms.34739","article-title":"Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications","volume":"16","author":"Marino","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib218","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.744064","article-title":"Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis","volume":"11","author":"Yu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib219","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.18632\/oncotarget.7067","article-title":"Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival","volume":"7","author":"Morris","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.04.003_bib220","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1038\/s41598-019-41098-0","article-title":"Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator","volume":"9","author":"Oh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.04.003_bib221","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-021-01331-9","article-title":"Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer","volume":"20","author":"Fang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib222","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib223","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12943-021-01371-1","article-title":"Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer","volume":"20","author":"Nagasaka","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib224","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13046-024-03026-7","article-title":"Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation","volume":"43","author":"Ren","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib226","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer: current status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.semcancer.2026.04.003_bib227","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.21037\/tlcr-24-379","article-title":"Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence","volume":"13","author":"Zhao","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib228","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","article-title":"Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics","volume":"54","author":"Zhu","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib229","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lungcan.2016.07.024","article-title":"Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung","volume":"100","author":"Naito","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib230","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.7150\/jca.92101","article-title":"An Investigation of the Immune Microenvironment and Genome during Lung Adenocarcinoma Development","volume":"15","author":"Wang","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib231","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139073","article-title":"Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma","volume":"10","author":"Banat","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.semcancer.2026.04.003_bib232","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.2147\/CMAR.S199832","article-title":"M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer","volume":"11","author":"Cao","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib233","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/jcmm.12109","article-title":"The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients","volume":"17","author":"Pantano","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib234","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib235","doi-asserted-by":"crossref","DOI":"10.30621\/jbachs.2019.625","article-title":"New Insight of Tumor Microenvironment in Non-Small Cell Lung Cancer","author":"Sever","year":"2019","journal-title":"J. Basic Clin. Health Sci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib236","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1158\/0008-5472.CAN-20-0069","article-title":"Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non\u2013Small Cell Lung Carcinoma","volume":"80","author":"Zheng","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.04.003_bib237","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1340","article-title":"Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil","volume":"13","author":"Peng","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib238","article-title":"Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib239","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.04.003_bib240","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/1471-2407-12-580","article-title":"Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment","volume":"12","author":"Heuvers","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib241","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54671-7","article-title":"Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development","volume":"15","author":"Takano","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib242","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00262-022-03252-y","article-title":"Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer","volume":"72","author":"Gao","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2026.04.003_bib243","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2018.01.022","article-title":"Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer","volume":"117","author":"Barua","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib244","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","article-title":"The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib245","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ctrv.2013.10.001","article-title":"The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets","volume":"40","author":"Wood","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.semcancer.2026.04.003_bib246","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1605","article-title":"Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib247","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12943-024-02177-7","article-title":"Single-cell RNA sequencing reveals immune microenvironment niche transitions during the invasive and metastatic processes of ground-glass nodules and part-solid nodules in lung adenocarcinoma","volume":"23","author":"Ren","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib248","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41571-025-01021-1","article-title":"Tumour and microenvironment crosstalk in NSCLC progression and response to therapy","volume":"22","author":"Rahal","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib249","article-title":"Spatial Immunophenotyping of the Tumor Microenvironment in Non-Small Cell Lung Cancer","author":"Backman","year":"2022","journal-title":"SSRN Electron. J."},{"key":"10.1016\/j.semcancer.2026.04.003_bib250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/or.2024.8714","article-title":"Advances of HIF\u20111\u03b1\/glycolysis axis in non\u2011small cell lung cancer (Review)","volume":"51","author":"Shi","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2026.04.003_bib251","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.613114","article-title":"Tumor Hypoxia Regulates Immune Escape\/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies","volume":"11","author":"Abou Khouzam","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib252","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcancer.2023.11.001","article-title":"Hypoxia signaling and metastatic progression","volume":"97","author":"Schito","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib253","article-title":"Metabolic reprogramming and therapeutic targeting in non-small cell lung cancer: emerging insights beyond the Warburg effect","volume":"15","author":"Cai","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib254","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15698\/cst2019.01.171","article-title":"Regulation of T cell antitumor immune response by tumor induced metabolic stress","volume":"3","author":"Chalmin","year":"2019","journal-title":"Cell Stress"},{"key":"10.1016\/j.semcancer.2026.04.003_bib255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fmolb.2019.00060","article-title":"Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors","volume":"6","author":"Chambers","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib256","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231106","article-title":"Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer","volume":"222","author":"Robles-Ote\u00edza","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib257","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1021\/acs.jproteome.3c00924","article-title":"Metabolomic Profiling of Tumor Tissues Unveils Metabolic Shifts in Non-Small Cell Lung Cancer Patients with Concurrent Diabetes Mellitus","volume":"23","author":"Lyu","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib258","article-title":"Lipidomic and metabolomic analysis reveals changes in biochemical pathways for non-small cell lung cancer tissues","volume":"1867","author":"C\u00edfkov\u00e1","year":"2022","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.semcancer.2026.04.003_bib259","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.21037\/tlcr-22-377","article-title":"Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer","volume":"11","author":"Foureau","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib260","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41467-025-56546-x","article-title":"Spatially mapping the tumour immune microenvironments of non-small cell lung cancer","volume":"16","author":"Desharnais","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib261","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.18632\/oncotarget.26748","article-title":"An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma","volume":"10","author":"Givechian","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.04.003_bib262","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrc2255","article-title":"A microenvironmental model of carcinogenesis","volume":"8","author":"Gatenby","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib263","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1379971","article-title":"Exploring the multifaceted role of direct interaction between cancer cells and fibroblasts in cancer progression","volume":"11","author":"Dhungel","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib264","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","article-title":"Stromal cells in the tumor microenvironment: accomplices of tumor progression?","volume":"14","author":"Zhao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2026.04.003_bib265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-024-02205-6","article-title":"Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib266","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-024-03242-1","article-title":"Advances in non-small cell lung cancer mechanomedicine: deciphering the signaling networks that govern tumor-TME interactions","volume":"43","author":"Gargalionis","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib267","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40364-024-00566-0","article-title":"Oncogenic alterations in advanced NSCLC: a molecular super-highway","volume":"12","author":"Friedlaender","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib268","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib269","article-title":"Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer","volume":"28","author":"Kim","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.semcancer.2026.04.003_bib270","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70219","article-title":"Profiling of Extracellular Vesicles of Non-Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance","volume":"15","author":"C\u00e1ceres-Verschae","year":"2026","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.semcancer.2026.04.003_bib271","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41392-024-02045-2","article-title":"CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.semcancer.2026.04.003_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101063","article-title":"Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape","volume":"57","author":"Simard","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.semcancer.2026.04.003_bib273","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8780","article-title":"Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers","volume":"8","author":"Mugarza","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcancer.2026.04.003_bib274","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1038\/s41467-021-26214-x","article-title":"Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry","volume":"12","author":"Van Maldegem","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib275","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl6464","article-title":"Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor\u2013induced immune responses","volume":"10","author":"Cole","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcancer.2026.04.003_bib276","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12943-024-01991-3","article-title":"Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1\/PD-L1 axis blockade via Id1 downregulation","volume":"23","author":"Puyalto","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib277","article-title":"A Phase 1\/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations","volume":"6","author":"Riess","year":"2025","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.semcancer.2026.04.003_bib278","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41698-023-00355-2","article-title":"Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity","volume":"7","author":"Kleczko","year":"2023","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib279","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/2326-6066.CIR-19-0056","article-title":"ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome","volume":"7","author":"Oh","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtho.2022.10.003","article-title":"Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study","volume":"18","author":"Girard","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib281","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib282","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-024-05035-8","article-title":"Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging","volume":"22","author":"Monkman","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib283","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12943-025-02287-w","article-title":"Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"24","author":"Cui","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib284","article-title":"Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures","volume":"6","author":"Peyraud","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib285","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41698-024-00626-6","article-title":"Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome","volume":"8","author":"Zhao","year":"2024","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib286","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.903562","article-title":"Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer","volume":"13","author":"Kandra","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib287","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68779-9","article-title":"CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy","volume":"14","author":"Yaga","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.04.003_bib288","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtho.2020.11.007","article-title":"Combination of Immunotherapy and Antiangiogenic Therapy in Cancer\u2014a Rational Approach","volume":"16","author":"Padda","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib289","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.jtho.2021.07.009","article-title":"IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC","volume":"16","author":"Socinski","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib290","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1200\/JCO.23.01891","article-title":"Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR - or ALK -Rearranged or Translocated Non\u2013Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)","volume":"42","author":"Park","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib291","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1470-2045(22)00382-5","volume":"23","author":"Lu","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib292","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S2213-2600(23)00135-2","volume":"11","author":"Lu","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib293","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jtho.2020.10.004","article-title":"Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC","volume":"16","author":"Herbst","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib294","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/s41591-025-03658-y","article-title":"Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial","volume":"31","author":"Zhou","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib295","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1158\/1078-0432.CCR-24-1561","article-title":"Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1\u2013Positive NSCLC: A Phase II Trial (EAST ENERGY)","volume":"30","author":"Aokage","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib296","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41392-024-01992-0","article-title":"Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)","volume":"9","author":"Duan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.semcancer.2026.04.003_bib297","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-025-01061-7","article-title":"Treatment of NSCLC after chemoimmunotherapy \u2014 are we making headway?","author":"Reck","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib298","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature21724","article-title":"Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming","volume":"544","author":"Tian","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib299","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/cancers17121912","article-title":"Spatial Transcriptomics in Lung Cancer and Pulmonary Diseases: A Comprehensive Review","volume":"17","author":"Kang","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.04.003_bib300","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1515","article-title":"Single-cell and spatial transcriptomics reveal POSTN+ cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.04.003_bib301","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41421-023-00591-7","article-title":"Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.semcancer.2026.04.003_bib302","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cac2.12023","article-title":"Overview of multiplex immunohistochemistry\/immunofluorescence techniques in the era of cancer immunotherapy","volume":"40","author":"Tan","year":"2020","journal-title":"Cancer Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib303","article-title":"Multiplex imaging analysis of the tumor immune microenvironment for guiding precision immunotherapy","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib304","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1158\/0008-5472.CAN-23-1698","article-title":"Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non\u2013Small Cell Lung Cancer","volume":"84","author":"Rigamonti","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.04.003_bib305","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","article-title":"Single-cell spatial landscapes of the lung tumour immune microenvironment","volume":"614","author":"Sorin","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.04.003_bib306","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41374-020-0417-4","article-title":"Multiplexed ion beam imaging (MIBI) for characterization of the tumor microenvironment across tumor types","volume":"100","author":"Ptacek","year":"2020","journal-title":"Lab. Invest"},{"key":"10.1016\/j.semcancer.2026.04.003_bib307","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102362","article-title":"Spatial metabolomics principles and application to cancer research","volume":"76","author":"Planque","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib308","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00432-021-03834-w","article-title":"Subtyping non-small cell lung cancer by histology-guided spatial metabolomics","volume":"148","author":"Neumann","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib309","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cac2.12310","article-title":"Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients","volume":"42","author":"Shen","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.semcancer.2026.04.003_bib310","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41592-025-02824-x","article-title":"Highly multiplexed 3D profiling of cell states and immune niches in human tumors","volume":"22","author":"Yapp","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.semcancer.2026.04.003_bib311","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1158\/1078-0432.CCR-18-2495","article-title":"Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging","volume":"25","author":"Xu","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib312","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1529949","article-title":"Editorial: Investigating tumor immunotherapy responses in lung cancer using deep learning","volume":"15","author":"Qin","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib313","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40364-024-00561-5","article-title":"Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.semcancer.2026.04.003_bib314","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1186\/s12885-022-10081-w","article-title":"Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer","volume":"22","author":"R\u0105czkowska","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.04.003_bib315","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41698-024-00765-w","article-title":"Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images","volume":"8","author":"Patkar","year":"2024","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.semcancer.2026.04.003_bib316","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41588-025-02351-7","article-title":"Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer","volume":"57","author":"Aung","year":"2025","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2026.04.003_bib317","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12929-022-00879-y","article-title":"Spatial multi-omics analyses of the tumor immune microenvironment","volume":"29","author":"Hsieh","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.semcancer.2026.04.003_bib318","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006234","article-title":"Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody","volume":"11","author":"Song","year":"2023","journal-title":"J. Immunother. Cancer"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:44:58Z","timestamp":1788486298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X26000477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":318,"alternative-id":["S1044579X26000477"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.04.003","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor microenvironment evolution in lung cancer: Spatio-temporal dynamics and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}